Skip to main content

Table 4 The success rate of cefaclor for all patients and that for patients with secondary treatment

From: Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study

 

All (n = 233)

< 50 years (n = 34)

> 50 years (n = 199)

 

Success

Fail

Success

Fail

Success

Fail

P value

All

219 (94.0)

14 (6.0)

33 (97.1)

1 (2.9)

186 (93.5)

13 (6.5)

< 0.001

Pathogens with the failure of cefaclor

Escherichia coli

156 (97.5)

4 (2.5)

33 (97.1)

1 (2.9)

128 (97.7)

3 (2.3)

0.975

Klebsiella species

18 (94.7)

1 (5.3)

1 (100)

0

17 (94.4)

1 (5.6)

0.971

Escherichia coli-ESBL

11 (61.1)

7 (38.9)

1 (100)

0

10 (58.8)

7 (41.2)

0.714

Staphylococcus species

5 (83.3)

1 (16.7)

2 (100)

0

3 (75.0)

1 (25.0)

0.741

Enterococcus faecalis

3 (75.0)

1 (25.0)

0

0

3 (75.0)

1 (25.0)

1

  1. Unless otherwise stated, the number of patients with percentages in parentheses
  2. ESBL Extended spectrum beta-lactamase